Get to know Aptinyx better with 6 real example sentences.
Aptinyx in a sentence
Using Aptinyx
- In the example corpus, aptinyx often appears in combinations such as: of aptinyx, aptinyx during.
Context around Aptinyx
- Average sentence length in these examples: 20.2 words
- Position in the sentence: 1 start, 5 middle, 0 end
- Sentence types: 6 statements, 0 questions, 0 exclamations
Corpus analysis for Aptinyx
- In this selection, "aptinyx" usually appears in the middle of the sentence. The average example has 20.2 words, and this corpus slice is mostly made up of statements.
- Around the word, molecules stand out and add context to how "aptinyx" is used.
- Recognizable usage signals include shares of aptinyx during the and shares of aptinyx in a. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "aptinyx" sits close to words such as aaba, aafc and aaib, which helps place it inside the broader word index.
Example types with aptinyx
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Spark Investment Management LLC acquired a new stake in Aptinyx during the 4th quarter worth $74,000. (17 words)
None of the molecules Aptinyx has advanced into clinical development are subject to any Allergan option right. (17 words)
American International Group Inc. purchased a new position in shares of Aptinyx during the 2nd quarter worth approximately $63,000. (20 words)
Finally, BMO Capital Markets restated a “buy” rating and set a $13.00 price target on shares of Aptinyx in a report on Friday, August 14th. (26 words)
Weiss Asset Management LP bought a new position in shares of Aptinyx during the 2nd quarter valued at approximately $65,000. (21 words)
American International Group Inc. purchased a new position in shares of Aptinyx during the 2nd quarter worth approximately $63,000. (20 words)
Example sentences (6)
American International Group Inc. purchased a new position in shares of Aptinyx during the 2nd quarter worth approximately $63,000.
Finally, BMO Capital Markets restated a “buy” rating and set a $13.00 price target on shares of Aptinyx in a report on Friday, August 14th.
Nuveen Asset Management LLC purchased a new stake in shares of Aptinyx during the second quarter worth about $574,000.
Spark Investment Management LLC acquired a new stake in Aptinyx during the 4th quarter worth $74,000.
Weiss Asset Management LP bought a new position in shares of Aptinyx during the 2nd quarter valued at approximately $65,000.
None of the molecules Aptinyx has advanced into clinical development are subject to any Allergan option right.
Common combinations with aptinyx
These word pairs occur most frequently in English texts:
- of aptinyx 4×
- aptinyx during 4×